OTC · RDGL
Healthcare · Medical - Devices
$0.04
Down-$0.00 (-0.68%)
Updated Oct 8, 2026, 6:40 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · RDGL
1M range · 0 trading sessions · Daily adjusted prices
RDGL does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning RDGL.
Company
Market Activity
Research & News
RDGL research
Company profile and research snapshot.
VIVOS INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Vivos Therapeutics is implementing a restructuring plan targeting $3. 6 million in annual savings while expanding several revenue initiatives that management believes could support cash flow positivity by late 2026 or early 2027.
Yahoo · Sep 8, 2026
Company Continues to Make Significant Progress to Enhance Stockholders' Equity and Satisfy Nasdaq Listing RequirementsLITTLETON, Colo., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (Nasdaq: VVOS), a medical device and healthcare services company focused on developing and commercializing diagnostic and treatment methods for patients with obstructive sleep apnea ("OSA") and other health conditions related to breathing and sleep disorders, today announced t
Yahoo · Sep 3, 2026
The Elsevier journal publication characterizes PrecisionGel’s biomolecular release properties, adding peer-reviewed support for Vivos Inc. ’s (USOTC:RDGL) clinical, regulatory and potential licensing efforts.
Yahoo · Sep 3, 2026
Kennewick, WA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company developing Precision Radionuclide Therapy™ (PRnT) for cancerous tumors in humans and animals, today announced the peer-reviewed publication of a paper describing the PrecisionGel™ thermogel polymer platform in the Journal of Drug Delivery Science and Technology. PrecisionGel™ is the polymer carrier component of both IsoPet® and RadioGel® and is also available independently to pharmaceutical and b
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RDGL.
